- According to current figures, the annual consumption of medicines in Mexico amounts to 4.8 billion pieces.
- Since 1997, the marketing of generic drugs in our country has been approved.
- To date, it is the main treatment option for Mexicans due to its low cost.
For 25 years the generic drugs They arrived in Mexico as a low-cost healing option. Since then they have been a source of controversy among health professionals because some support them and others are against their use. Although the truth is that the opinion of patients is quite favorable.
In that sense, part of the division of opinions is found in the efficacy of this type of drug. To date, it is questioned that their economic prices generate partial recoveries as effects that increase the risk of suffering relapses. In addition, they also encourage drug resistance.
Drug use in Mexico
Despite the above, during the Annual Convention of the National Association of Generic Drug Distributors and Laboratories (Dilameg) the figures on its consumption in our country were presented. As a guest was the head of the Ministry of Economy, Tatiana Clouthierwho stated that of the total number of drugs marketed in Mexico 92.6 percent is low cost.
“According to information from lnefam, in Mexico the annual consumption of medicines amounts to approximately 4.8 billion pieces. Of this figure, 7.4 percent corresponds to patent or single-source drugs. While 92.6 percent is generic, that is, of the total number of drugs sold in our country, between 80 and 90 percent are generic.
He added that the production of generic drugs in our country it is extremely relevant because this type of product makes it possible for most Mexican families to have access to affordable treatment.
For its part, Santiago Bojalil, President of Dilameg, stressed that this body made up of 25 laboratories and 15 distributors -all Mexicans- is an ally of the patient who for various reasons does not have social security. With this in mind, those who make it up come daily to more than 34 thousand points of sale throughout the country.
“Today more than ever, let’s continue investing, developing, proposing and growing as the national industry that characterizes us. Our Mexican economy needs us. For your health, generics, for your economy, too”.
In his participation, Patrick Devlyn, president of the Health Commission of the Business Coordinating Council (CCE), endorsed the commitment of the highest business leadership to work with Dilameg to achieve an effective dialogue with authorities from the Ministry of Health, Economy, Cofepris, IMSS and Insabi.
“The foregoing to have a regulatory framework that facilitates the innovation and development of generic drugs, and expand its penetration in public and private sector acquisitions, to have a reduction in patient spending.”
For his part, Luis Ángel Blanco, Undersecretary of Health of the Government of Quintana Roo, highlighted the scientific contribution that Dilameg makes in the manufacture of medicines for hospital use, and said that this motivates this agency to continue strategies for a better patient care.
Also read:
Dr. Sim plus Amazon? Millionaire creates a virtual generic pharmacy
Do you know the differences between biocomparable and generic drugs?
They present an initiative to promote generics in medical prescriptions, do you agree?